BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31243614)

  • 21. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
    Pose E; Sancho-Bru P; Coll M
    Methods Mol Biol; 2019; 1981():249-257. PubMed ID: 31016659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.
    Chaudhary K; Liedtke C; Wertenbruch S; Trautwein C; Streetz KL
    J Hepatol; 2013 Dec; 59(6):1292-8. PubMed ID: 23928400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
    Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockout of the Tachykinin Receptor 1 in the Mdr2
    Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
    Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
    Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
    Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined Inhibition of the TGF-β1/Smad Pathway by
    Shen Y; Jiang B; Zhang C; Wu Q; Li L; Jiang P
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis.
    Carpino G; Nevi L; Overi D; Cardinale V; Lu WY; Di Matteo S; Safarikia S; Berloco PB; Venere R; Onori P; Franchitto A; Forbes SJ; Alvaro D; Gaudio E
    Hepatology; 2020 Mar; 71(3):972-989. PubMed ID: 31330051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.
    Plum W; Tschaharganeh DF; Kroy DC; Corsten E; Erschfeld S; Dierssen U; Wasmuth H; Trautwein C; Streetz KL
    Am J Pathol; 2010 May; 176(5):2236-46. PubMed ID: 20382701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of cd39/entpd1 results in hepatic insulin resistance.
    Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
    Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.
    Jones H; Hargrove L; Kennedy L; Meng F; Graf-Eaton A; Owens J; Alpini G; Johnson C; Bernuzzi F; Demieville J; DeMorrow S; Invernizzi P; Francis H
    Hepatology; 2016 Oct; 64(4):1202-1216. PubMed ID: 27351144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
    Künzli BM; Nuhn P; Enjyoji K; Banz Y; Smith RN; Csizmadia E; Schuppan D; Berberat PO; Friess H; Robson SC
    Gastroenterology; 2008 Jan; 134(1):292-305. PubMed ID: 18036594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis.
    Henkel C; Roderfeld M; Weiskirchen R; Berres ML; Hillebrandt S; Lammert F; Meyer HE; Stühler K; Graf J; Roeb E
    Proteomics; 2006 Dec; 6(24):6538-48. PubMed ID: 17109383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.
    Strack I; Schulte S; Varnholt H; Schievenbusch S; Töx U; Wendland K; Steffen HM; Drebber U; Dienes HP; Odenthal M
    Lab Invest; 2011 Feb; 91(2):252-61. PubMed ID: 20921947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.
    Kennedy L; Meadows V; Demieville J; Hargrove L; Virani S; Glaser S; Zhou T; Rinehart E; Jaeger V; Kyritsi K; Pham L; Alpini G; Francis H
    Lab Invest; 2020 Jun; 100(6):837-848. PubMed ID: 32054995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease.
    Friedman DJ; Künzli BM; A-Rahim YI; Sevigny J; Berberat PO; Enjyoji K; Csizmadia E; Friess H; Robson SC
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16788-93. PubMed ID: 19805374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches.
    Chen L; Luo M; Sun X; Qin J; Yu C; Wen Y; Zhang Q; Gu J; Xia Q; Kong X
    Cell Death Dis; 2016 Jun; 7(6):e2257. PubMed ID: 27277679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
    Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
    Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
    Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
    Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.